A method for preparing andrographolide derivatives using industrial chromatography technology

Through small-pore adsorption resin column and high-pressure chromatography, high-purity isocarbazide-19-sulfate sodium was prepared, which solved the problem of poor solubility of carbazide and achieved low-cost and efficient industrial production and potential anti-inflammatory activity. .

CN113121483BActive Publication Date: 2024-11-12JIANGZI QINGFENG PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN201911410842.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2019-12-31
Publication Date
2024-11-12
Estimated Expiration
2039-12-31

AI Technical Summary

Technical Problem

The poor solubility of punctate lactone limits its application and clinical efficacy in water. The existing derivative preparation methods are costly and are not suitable for industrial production.

Method used

Using small-pore adsorption resin column chromatography and high-pressure chromatography column chromatography system, iso-isoprolide-19-sulfate sodium isoprolide-19-sulfate through gradient elution and dual-wavelength ultraviolet online detector, which improves its water solubility and purity, which is suitable for Industrialized production.

Benefits of technology

It realizes the preparation of isocarbazide-19-sulfate sodium with simple operation, low cost and purity of up to 98%. It is suitable for mass production, and significantly reduces process costs, improves process reproducibility and potential anti-inflammatory activity of the product. .

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN113121483B_ABST
    Figure CN113121483B_ABST
Patent Text Reader

Abstract

The invention discloses a method for preparing andrographolide derivatives by industrial chromatography technology, comprising first enriching the total sulfonated andrographolide by a small-pore adsorption resin, and then separating and purifying by an industrial chromatographic column to obtain isoandrographolide-19-sodium sulfate, the purity of which is above 98%. The invention can realize real-time online monitoring of the separation process, has good process reproducibility, simple operation, short preparation time, and less organic solvent consumption, and can be mass-produced industrially.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention discloses an andrographolide derivative and a preparation method thereof, and particularly relates to a method for preparing the andrographolide derivative by utilizing industrial chromatography technology. Background Art

[0002] Andrographolide is a diterpenoid compound extracted from the whole herb of Andrographis paniculata (Burm.F.) Nees, a plant of the Acanthaceae family. It has antibacterial, anti-inflammatory, detoxifying and other effects and is an important active natural product. Andrographolide has poor solubility and is almost insoluble in water. In order to increase its water solubility, facilitate its use and improve its clinical efficacy, it is usually made into water-soluble derivatives, such as sodium bisulfite adducts, succinic acid half ester monopotassium salt / potassium sodium salt, sulfate esters, etc. At present, Xiyanping injection, one of the most widely used andrographolide-related products in clinical practice, is a traditional Chinese medicine injection prepared with total sulfonate of andrographolide (prepared by sulfonation reaction of andrographolide and sulfuric acid) as raw materials. It has a broad spectrum of antibacterial and antiviral effects and has significant effects in resisting bacterial and viral infections and rapidly reducing fever. In recent years, more and more studies have been conducted on the chemical composition, pharmacological activity and clinical application of Xiyanping injection (Xu Hui, Wang Gongfu, Han Fei, et al. Isolation and characterization of four new derivatives in the sulfation reaction system of andrographolide [J]. Acta Chimica Sinica, 2009, 67(3): 261-265.).

[0003] Therefore, developing a new andrographolide derivative will be of great research significance. Summary of the invention

[0004] The invention provides a new andrographolide derivative and a preparation method of the derivative which has the advantages of simple operation, low cost and is suitable for industrial production.

[0005] In the first aspect of the present invention, there is provided an andrographolide derivative shown in formula I, the chemical name of which is sodium isoandrographolide-19-sulfate, and the chemical structure is as follows:

[0006]

[0007] Another aspect of the present invention provides a method for preparing an andrographolide derivative shown in formula I.

[0008]

[0009] The steps include:

[0010] (1) Small pore resin column chromatography: Take the total sulfonated andrographolide and add an appropriate amount of water to dissolve it, then load it onto a small pore adsorption resin column, use the mixed solvent system 1 for elution, combine the eluates, and concentrate to dryness to obtain a crude product of isoandrographolide-19-sulfate sodium (Formula I);

[0011] (2) Purification by high pressure chromatography column system: The crude product of isoandrographolide-19-sodium sulfate (Formula I) is dissolved with an appropriate amount of solvent 1, loaded onto a high pressure chromatography column, eluted with solvent system 2, and the separation is detected with a dual wavelength ultraviolet online detector. Fractions are received according to the absorption peak height and peak shape under the detection condition of 225 nm wavelength, and the eluents are combined, concentrated under reduced pressure, and dried.

[0012] Preferably, in step (1), the small pore adsorption resin is a polystyrene-divinylbenzene polymer.

[0013] Preferably, in step (1), the small pore adsorption resin filler is selected from CG161 and MCI GEL CHP20P.

[0014] Preferably, in step (1), the water is purified water.

[0015] Preferably, in step (1), the mixed solvent system 1 is a mixed solution of methanol and water, preferably 0-30%

[0016] (V / V) methanol aqueous solution or 0-30% (V / V) ethanol aqueous solution.

[0017] Preferably, in step (1), the elution is a gradient elution, such as 0%, 10%, 20% (V / V) in sequence.

[0018] The elution was performed with aqueous methanol or sequentially with 0%, 10%, 20%, and 30% (V / V) aqueous ethanol.

[0019] Preferably, in step (1), the concentration temperature is 40-55°C, preferably 45-50°C.

[0020] Preferably, in step (2), the high pressure chromatography column is filled with reverse chromatography filler; preferably UniSil C18, UniSil C18 Ultra or UniSil C18 AQ.

[0021] Preferably, in step (2), the high pressure chromatography column chromatography system is a dynamic axial compression high pressure chromatography column system; more preferably, a DAC-HB300 dynamic axial compression column and / or a UniSil C18 10 μm filler are used.

[0022] Preferably, in step (2), the wavelength is 200 to 300 nm, and the detection wavelength is preferably 225 nm.

[0023] Preferably, in step (2), solvent 1 is a methanol aqueous solution or an acetonitrile aqueous solution, preferably a 10%-30% methanol aqueous solution or a 5%-20% acetonitrile aqueous solution (such as a 10% acetonitrile aqueous solution);

[0024] Preferably, in step (2), the mixed solvent system 2 is a mixed solution of methanol and water or a mixed solution of acetonitrile and water, preferably a 15% to 25% (V / V) methanol aqueous solution or a 10% to 15% (V / V) acetonitrile aqueous solution;

[0025] Preferably, in step (2), the elution is a gradient elution, such as eluting with 10%, 15% (V / V) acetonitrile-water solution in sequence or eluting with 15%, 20%, 25% (V / V) methanol-water solution in sequence;

[0026] Preferably, in step (2), the concentration temperature is 40 to 55°C, preferably 45 to 50°C.

[0027] Preferably, in step (2), the purity of isandrographolide-19-sodium sulfate in the eluent is greater than 98%.

[0028] Beneficial technical effects of the present invention:

[0029] 1. The present invention provides a compound having potential anti-inflammatory activity as shown in formula (I).

[0030] 2. The method for preparing sodium isoandrographolide-19-sulfate shown in the present invention is easy to operate, has a high yield, a purity of more than 98.0%, and is suitable for industrial production.

[0031] 3. The preparation method of formula (I) of the present invention adopts a small-pore adsorption resin column and an industrial chromatography technology high-pressure chromatography purification process. The filler used is easy to regenerate and can be reused. The normal service life is long, and the cost can be significantly reduced. Real-time online monitoring is possible, the process has good reproducibility, simple operation, short preparation time, and a small amount of organic solvent is used, and large-scale industrial production can be achieved. BRIEF DESCRIPTION OF THE DRAWINGS

[0032] Figure 1 : H NMR spectrum of isoandrographolide-19-sulfate sodium;

[0033] Figure 2 : Isandrographolide-19-sulfate sodium NMR carbon spectrum;

[0034] Figure 3 : Embodiment 2 isoandrographolide-19-sodium sulfate HPLC chromatogram;

[0035] Figure 4 : Embodiment 3 isoandrographolide-19-sodium sulfate HPLC chromatogram. DETAILED DESCRIPTION

[0036] The chemical structural formula of isoandrographolide-19-sodium sulfate referred to in the following examples (the Arabic numerals in the structure are the positions of carbon atoms in the chemical structure):

[0037]

[0038] Example 1: Preparation of total sulfonate of andrographolide

[0039] Take 50L of anhydrous ethanol, put it in a reactor, slowly add 20L of concentrated sulfuric acid, stir evenly, add 50.00kg of andrographolide, stir, and place at room temperature for 72 hours. Control the temperature and add 50L of 95% ethanol, stir, add 50% sodium hydroxide solution to adjust the pH to 7.0, add ethanol to 85% alcohol content, let stand for 24 hours, filter, recover ethanol from the filtrate, concentrate into a thick paste, and vacuum dry to obtain total sulfonated andrographolide.

[0040] Example 2: Preparation of isoandrographolide-19-sodium sulfate

[0041] 10.12 kg of total sulfonated andrographolide obtained in Example 1 was taken, dissolved in an appropriate amount of purified water, and then loaded onto a CG161 small pore adsorption resin column, eluted with 0%, 10%, 20%, and 30% ethanol-water solutions by volume, and the eluted fractions containing isoandrographolide-19-sodium sulfate were combined and concentrated to dryness under reduced pressure at 45° C. to obtain a crude product of isoandrographolide-19-sodium sulfate; the crude product of isoandrographolide-19-sodium sulfate was dissolved in an appropriate amount of 10% methanol-water solution and then purified by a high pressure chromatography column system (DAC-HB300 dynamic axial compression column, UniSilC18 10μm filler 20kg), eluted with 15%, 20%, 25% methanol-water solution in turn, received fractions according to the absorption peak height and peak shape under the detection condition of 225nm wavelength, combined the eluate with the purity of isandrographolide-19-sodium sulfate greater than 98%, concentrated and dried under reduced pressure at 45℃, and obtained 116.48g of isandrographolide-19-sodium sulfate with a purity of 99.16% (its HPLC chromatogram is shown in Figure 3 ).

[0042] Example 3: Preparation of isoandrographolide-19-sodium sulfate

[0043] 20.02 kg of total andrographolide sulfonate obtained by implementing CN1349986A was taken, dissolved in an appropriate amount of purified water, and then loaded onto an MCI GEL CHP20P small-pore resin column, eluted with 0%, 10%, and 20% methanol-water solutions in turn, and the eluted fractions containing isoandrographolide-19-sodium sulfate were combined and concentrated to dryness under reduced pressure at 50° C. to obtain a crude product of isoandrographolide-19-sodium sulfate; the crude product of isoandrographolide-19-sodium sulfate was dissolved in an appropriate amount of 10% acetonitrile-water solution and then purified by a high-pressure chromatography column system (DAC-HB300 dynamic axial compression column, UniSil C18Ultra 10μm filler 20kg), eluted with 10% and 15% acetonitrile-water solution in volume ratio, received fractions according to the absorption peak height and peak shape under the detection condition of 225nm wavelength, combined the eluate with the purity of isandrographolide-19-sodium sulfate greater than 98%, concentrated under reduced pressure at 50℃ to dryness, and obtained 112.64g of isandrographolide-19-sodium sulfate with a purity of 99.03% (its HPLC chromatogram is shown in Figure 4 ).

[0044] The chemical structure of the compound isoandrographolide-19-sodium sulfate was identified by modern spectral techniques such as NMR and ESI-MS. Its physical and chemical properties are as follows:

[0045] White powder, molecular formula: C 20 H 29 O8SNa;

[0046] High resolution mass spectrometry ESI-MS m / z 429.1413 [M–Na] – (cald.for.C 20 H 29 O8S,429.1578). H NMR spectrum 1 H-NMR (400MH Z ) and C NMR 13 C-NMR (100MH Z ),See Figure 1 and Figure 2 , data see Table 1.

[0047] Table 1: Hydrogen and carbon spectrum data of isoandrographolide-19-sulfate sodium (400 / 100 MHz, DMSO)

[0048]

[0049] Example 4

[0050] Wistar rats, 200-220 g, were randomly divided into 6 groups (normal group, model group, and four dose groups of isoandrographolide-19-sulfate sodium). After chloral hydrate anesthesia, except for the normal group, which was given an equal amount of normal saline, the other groups of rats were subcutaneously injected with 0.1 mL of sterile 1% carrageenan saline suspension into the right hind foot plantar to induce inflammation. After 0.5 h of inflammation, different doses of isoandrographolide-19-sulfate sodium or normal saline were intravenously injected, and the administration volume was 1 mL / 100 g. The water volumetric method was used to determine the right hind foot plantar volume before inflammation and 1, 3, 5, and 7 h after inflammation, and the swelling rate and swelling inhibition rate were calculated. The swelling rate (%) was expressed as (Vt-Vn) / Vn*100, where Vn and Vt represent the foot volume before inflammation and the response time after inflammation, respectively. The swelling inhibition rate (%) was expressed as (average swelling rate of the model group - average swelling rate of the drug-treated group) / average swelling rate of the model group*100.

[0051] All data are expressed as means±SD, and the statistical differences between groups were analyzed using Tukey's test. P values ​​less than 0.05 were considered to be significantly different. The results of swelling rate and swelling inhibition rate are shown in Tables 2 and 3 below, respectively.

[0052] It can be seen from Tables 2 and 3 that the swelling peak was reached about 5 hours after carrageenan injection; sodium isoandrographolide-19-sulfate significantly inhibited foot swelling in a dose-dependent manner at 3, 5, and 7 hours within the dose range of 12.5-100.0 mg / kg (P<0.05 or P<0.01 or P<0.001), and the swelling inhibition rate at 5-7 hours reached 30-70%.

[0053] Table 2: Effects of sodium isoandrographolide-19-sulfate on carrageenan-induced foot swelling at different times

[0054]

[0055] Note: Compared with the normal group, ##P<0.01, ###P<0.001; compared with the model group, *P<0.05, **P<0.01, ***P<0.001.

[0056] Table 3: Inhibition rate of foot swelling by isoandrographolide-19-sulfate sodium at different time

[0057]

Claims

1. A method for preparing an andrographolide derivative represented by formula (I), comprising the following steps: (1) Small pore resin column chromatography: the total sulfonated andrographolide is dissolved in an appropriate amount of purified water, and then loaded onto a small pore adsorption resin column, and eluted with a mixed solvent system 1, the eluate is combined, and concentrated to dryness to obtain a crude product of isoandrographolide-19-sulfate sodium ester (Formula I); the small pore adsorption resin filler is selected from CG161 or MCI GEL CHP20P; the mixed solvent system 1 is 0-30% (V / V) methanol aqueous solution or 0-30% (V / V) ethanol aqueous solution; the elution is a gradient elution, eluting with 0%, 10%, 20% (V / V) methanol aqueous solution or 0%, 10%, 20%, 30% (V / V) ethanol aqueous solution in sequence; the concentration temperature is 40-55°C; (2) Purification by high pressure chromatography column system: the crude product of isoandrographolide-19-sodium sulfate (Formula I) is dissolved with an appropriate amount of solvent 1, loaded onto a high pressure chromatography column, eluted with solvent system 2, and the separation is detected by an ultraviolet online detector. The fractions are received according to the absorption peak height and peak shape under the detection condition of 225 nm wavelength, the eluents are combined, concentrated under reduced pressure, and dried; the high pressure chromatography column chromatography system is a dynamic axial compression high pressure chromatography column system, using a DAC-HB300 dynamic axial compression column, and using UniSil C18 10 μm or UniSil C18Ultra 10μm filler; the solvent 1 is 10% (V / V) methanol aqueous solution or 10% (V / V) acetonitrile aqueous solution; the solvent system 2 is 15%-25% (V / V) methanol aqueous solution or 10%-15% (V / V) acetonitrile aqueous solution; the elution is gradient elution, eluting with 10%, 15% (V / V) acetonitrile-water solution in sequence or eluting with 15%, 20%, 25% (V / V) methanol aqueous solution in sequence; the concentration temperature is 40-55°C; the wavelength is 225nm.

2. The preparation method according to claim 1, characterized in that: In step (1), the concentration temperature is 45-50°C.

3. The preparation method according to claim 1, wherein in step (2), the concentration temperature is 45-50°C.

4. The preparation method according to claim 1, wherein in step (2), the purity of isandrographolide-19-sodium sulfate in the eluent is greater than 98%.